On ECHEMI
Home > Drugs > Guangzhou Hanfang Pharmaceutical Company Limited
Guangzhou Hanfang Pharmaceutical Company Limited
  • Founded in:

    1998-09-24
  • Country:

    China China
  • Address:

    No. 8 Wenquan Avenue, Conghua, Guangzhou
  • Tax NO.:

    914401017124186087
  • Registered Funds:

    252.5643 million yuan
  • Website:

  • Email:

Related Drugs
Dopamine Capsules
This product is a compound preparation, its components are: levodopa and benserazide hydrochloride.
Name Description Content CAS NO. Registered Holders
Levodopa

It is converted into dopamine by dopa decarboxylase in the brain, improving the symptoms of Parkinson's disease

More

It is converted into dopamine by dopa decarboxylase in the brain, improving the symptoms of Parkinson's disease

59-92-7 36
Benserazide hydrochloride

It is a peripheral decarboxylase inhibitor that is not easy to enter the central nervous system. It only inhibits the conversion of peripheral levodopa into dopamine, reduces the adverse reactions of levodopa in the peripheral cardiovascular system, and reduces the dosage of levodopa.

More

It is a peripheral decarboxylase inhibitor that is not easy to enter the central nervous system. It only inhibits the conversion of peripheral levodopa into dopamine, reduces the adverse reactions of levodopa in the peripheral cardiovascular system, and reduces the dosage of levodopa.

14919-77-8 17
Vinorelbine tartrate
Name Description Content CAS NO. Registered Holders
Vinorelbine tartrate

Extract from the above information

More

Extract from the above information

125317-39-7 20
Inosine Granules
Name Description Content CAS NO. Registered Holders
Inosine

It participates in cellular energy metabolism and protein synthesis in the body, increases the activity of related metabolic enzymes, improves liver function, and promotes the recovery of damaged liver.

More

It participates in cellular energy metabolism and protein synthesis in the body, increases the activity of related metabolic enzymes, improves liver function, and promotes the recovery of damaged liver.

58-63-9 8
Carbocisteine Tablets
Each tablet of this product contains 250 mg of carbocisteine, and the excipients are medicinal starch, 10% starch slurry, medicinal dextrin, microcrystalline cellulose, magnesium stearate, and sodium carboxymethyl starch.
Name Description Content CAS NO. Registered Holders
S-Carboxymethyl-L-cysteine

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

More

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

250mg 2387-59-9 13
Starch

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

More

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

9005-25-8 79
10% starch slurry

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

More

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

0
Medicinal dextrin

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

More

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

0
Microcrystalline cellulose

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

More

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

9004-34-6 89
Magnesium stearate

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

More

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

557-04-0 61
Sodium carboxyl methylstarch

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

More

This product is a mucus regulator, which mainly acts on the secretion of bronchial glands, increasing the secretion of low-viscosity salivary mucin and reducing the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. It takes effect quickly after oral administration, and obvious therapeutic effects can be seen within 4 hours of taking it.

9063-38-1 46
Linoleic acid
Linoleic acid
Name Description Content CAS NO. Registered Holders
Linoleic acid

Extract from the above information

More

Extract from the above information

60-33-3 5
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.